This inventor holds 1 USPTO granted patent. Top assignee: Warner-Lambert Company. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Claude Jeffrey Calvitt: Innovator in Pharmaceutical Crystallization
Introduction
Claude Jeffrey Calvitt is a notable inventor based in Saline, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of new crystalline forms of therapeutic agents. His work has implications for the manufacturing processes of important medications.
Latest Patents
Calvitt holds a patent for "Anhydrous crystalline forms of gabapentin." This patent describes new crystalline anhydrous forms of gabapentin that are derived from gabapentin monohydrate. The innovative crystalline forms provide advantages in the manufacture of the therapeutic agent, enhancing its efficacy and stability.
Career Highlights
Calvitt has had a distinguished career, working with the Warner-Lambert Company, where he has focused on pharmaceutical innovations. His expertise in crystallization processes has positioned him as a key figure in the development of new drug formulations.
Collaborations
Throughout his career, Calvitt has collaborated with talented professionals, including Brian Tobias and Suresh R Babu. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical sciences.
Conclusion
Claude Jeffrey Calvitt's work in developing anhydrous crystalline forms of gabapentin exemplifies the impact of innovation in the pharmaceutical industry. His contributions continue to influence the manufacturing of therapeutic agents, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile